Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (17%) |
| Multi-statute (no §101) | 5 (83%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TCHERKASSKAYA, OLGA V | 1 | 55.2% | +46.3% |
| GREENE, IVAN A | 1 | 18.7% | +6.2% |
| TRAN, SUSAN T | 1 | 62.6% | +35.7% |
| AZPURU, CARLOS A | 1 | 83.8% | +10.6% |
| PURDY, KYLE A | 1 | 41.0% | +36.5% |
| ATKINSON, JOSHUA ALEXANDER | 1 | 55.3% | +34.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18284981 | METHOD FOR PREPARING MICROPARTICLES CONTAINING POORLY SOLUBLE DRUGS | TRAN, SUSAN T | 17d overdue |
| 17762701 | SUSTAINED-RELEASE MICROPARTICLES FOR SUSTAINED RELEASE OF DRUG | ATKINSON, JOSHUA ALEXANDER | 6d |
| 18856000 | MICROPARTICLES CONTAINING MOXIDECTIN AND SUSTAINED-RELEASE INJECTION COMPOSITION CONTAINING SAME | TCHERKASSKAYA, OLGA V | — |
| 18767008 | COMPOSITION FOR SUSTAINED-RELEASE INJECTION COMPRISING DESLORELIN | GREENE, IVAN A | — |
| 18325567 | SUSTAINED FORMULATION FOR PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE CONTAINING NALTREXONE AND METHOD USING THE SAME | AZPURU, CARLOS A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17723155 | SUSTAINED-RELEASE MICROPARTICLES FOR SUSTAINED RELEASE OF DRUG | PURDY, KYLE A | 25d overdue |
| 18284981 | METHOD FOR PREPARING MICROPARTICLES CONTAINING POORLY SOLUBLE DRUGS | TRAN, SUSAN T | 17d overdue |
| 17762701 | SUSTAINED-RELEASE MICROPARTICLES FOR SUSTAINED RELEASE OF DRUG | ATKINSON, JOSHUA ALEXANDER | 6d |
| 18856000 | MICROPARTICLES CONTAINING MOXIDECTIN AND SUSTAINED-RELEASE INJECTION COMPOSITION CONTAINING SAME | TCHERKASSKAYA, OLGA V | — |
| 18325567 | SUSTAINED FORMULATION FOR PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE CONTAINING NALTREXONE AND METHOD USING THE SAME | AZPURU, CARLOS A | — |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| 1615 | 1 |
| 1617 | 1 |
| 1611 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18856000 | MICROPARTICLES CONTAINING MOXIDECTIN AND SUSTAINED-RELEASE INJECTION COMPOSITION CONTAINING SAME | TCHERKASSKAYA, OLGA V | — | §103§112 | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18767008 | COMPOSITION FOR SUSTAINED-RELEASE INJECTION COMPRISING DESLORELIN | GREENE, IVAN A | 1619 | §103§112 | Non-Final OA | — | Pending | Jul 09, 2024 |
| 18284981 | METHOD FOR PREPARING MICROPARTICLES CONTAINING POORLY SOLUBLE DRUGS | TRAN, SUSAN T | 1615 | §102§103§112 | Final Rejection | 17d overdue | Pending | Sep 29, 2023 |
| 18325567 | SUSTAINED FORMULATION FOR PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE CONTAINING NALTREXONE AND METHOD USING THE SAME | AZPURU, CARLOS A | 1617 | §103§112 | Non-Final OA | — | Pending | May 30, 2023 |
| 17723155 | SUSTAINED-RELEASE MICROPARTICLES FOR SUSTAINED RELEASE OF DRUG | PURDY, KYLE A | 1611 | §103 | Final Rejection | 25d overdue | Pending | Apr 18, 2022 |
| 17762701 | SUSTAINED-RELEASE MICROPARTICLES FOR SUSTAINED RELEASE OF DRUG | ATKINSON, JOSHUA ALEXANDER | 1612 | §103§112 | Non-Final OA | 6d | Pending | Mar 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial